A possible side-effect of human erythropoietin therapy: Thrombosis of peripheral arterial reconstruction

European Journal of Vascular and Endovascular Surgery

Volumn 18, Issue 3, 1999, Pages 273-274

  Mingoli, A ^a   Sapienza, P ^b   Puggioni, A ^b   Modini, C ^b   Cavallaro, A ^b  

^a POLICLINICO UMBERTO I   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN; RECOMBINANT ERYTHROPOIETIN;

ADULT; ARTERY RECONSTRUCTION; ARTERY THROMBOSIS; ARTICLE; CASE REPORT; HEART FAILURE; HEMODIALYSIS; HEMOGLOBIN DETERMINATION; HUMAN; KIDNEY FAILURE; MALE; PRIORITY JOURNAL; UREMIA;

EID: 0033199652     PISSN: 10785884     EISSN: None     Source Type: Journal    
DOI: 10.1053/ejvs.1999.0889     Document Type: Article

References (6)

1. Wheeler DC. Cardiovascular disease in patients with chronic renal failure. Lancet 1996; 348: 1673-1674.
2. Isiklar MH, Kulbaski M, MacDonald MJ, Lumsden AB. Infrainguinal bypass in end-stage renal disease: When is it justified? Semin Vasc Surg 1997; 10: 42-48.
3. Moreno F, Aracil FJ, Perez R, Valderrabano F. Controlled study on the improvement of quality of life in elderly hemodialysis patients after correcting end-stage renal disease-related anemia with erythropoietin. Am J Kidney Dis 1996; 27: 548-556.
4. Churchill DN, Muirhead N, Goldstein M et al. Probability of thrombosis of vascular access among hemodialysis patients treated with recombinant human erythropoietin. J Am Soc Nephrol 1994; 4: 1809-1813.
5. Iseki K, Nishime K, Uehara H et al. Increased risk of cardiovascular disease with erythropoietin in chronic dialysis patients. Nephron 1996; 72: 30-36.
6. Besarab A, Bolton WK, Browne JK et al. The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis. N Engl J Med 1998; 339: 584-590.